Viewing Study NCT03337451


Ignite Creation Date: 2025-12-24 @ 11:39 PM
Ignite Modification Date: 2025-12-25 @ 9:29 PM
Study NCT ID: NCT03337451
Status: COMPLETED
Last Update Posted: 2019-01-28
First Post: 2017-10-18
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Follow up Protocol to the Phase I/II Study of OPN-305 in Second-line or Third-line Lower Lower Risk Myelodysplastic Syndrome
Sponsor: Opsona Therapeutics Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module Annotation Module